Unique molecular and cellular features of acute myelogenous leukemia stem cells

Leukemia

Volumn 16, Issue 4, 2002, Pages 559-562

  Jordan, C T ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

AML; Animal models; Cell cycle; Leukemia; NF B; Stem cell

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BLAST CELL; BONE MARROW CELL; CANCER STAGING; CANCER THERAPY; CELL DIFFERENTIATION; CELL POPULATION; CELL TYPE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FRANCE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; UNITED STATES;

ACUTE DISEASE; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID;

EID: 0036234659     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402446     Document Type: Review

References (49)

1. Acute myeloid leukemia
2. Molecular genetics of acute myeloid leukaemia
3. Preleukemia: Does it exist?
4. Acute leukaemia: Development, remission/relapse pattern, relationship between normal and leukaemic haemopoiesis, and the 'sleeper-to-feeder' stem cell hypothesis
5. Clonogenic cells in acute myeloblastic leukemia
6. Maturation hierarchy of leukemic stem cells
7. On the maturation order of AML cells: A distinction on the basis of self-renewal properties and immunologic phenotypes
8. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia
9. Characteristics and analysis of normal and leukemic stem cells: Current concepts and future directions
10. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
11. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
12. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo
13. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-
14. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117)
15. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells
16. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
17. Monoclonal antibody therapy of cancer
18. Antibody-targeted therapy for myeloid leukemia
19. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture
20. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia
21. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells
22. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells
23. The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance
24. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis
25. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells
26. Enhanced degradation of 1-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells
27. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
28. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells
29. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription
30. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway
31. Hematologic malignancies
32. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking differentiation and rapid induction of an acute myelogenous leukemia
33. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL
34. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia
35. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice
36. Human AML1/MDS1/EV11 fusion protein induces an acute myelogenous leukemia (AML) in mice: A model for human AML
37. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice
38. The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells
39. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice
40. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation
41. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
42. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
43. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines
44. A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations
45. Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor
46. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
47. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
48. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model
49. Reversibility of acute B-cell leukaemia induced by BCR-ABL1